On 13 February, Clifford Lane went to a Washington, D C –area airport to catch a flight to Japan, where he would help launch a study of an experimental drug, remdesivir, against coronavirus disease 2019 (COVID-19) Lane is a deputy director at the U S National Institute of Allergy and Infectious Diseases and a right-hand man to Anthony Fauci, head of NIAID and the top research scientist in the country advising the White House on the outbreak of the virus As Lane waited to board his plane, he was told that his final destination had changed “I get an email, ‘You need to go to China ’ It’s like, are you kidding?” Lane had been selected as one of two U S scientists to join a World Health Organization team of 13 international researchers who would tour five different cities with 12 Chinese colleagues to get a firsthand look at the coronavirus epidemic there The joint mission, which ran from 16–23 February led to a report that offered more details about the clinical course of COVID-19 and the epidemiology in China than had appeared anywhere before